Annexon registers Phase 3 extension study of vonaprument for geographic atrophySep 8Trial updateAnnexon, Inc.vonaprument
Annexon reports Q2 2026 results, sets tanruprubart BLA for fourth quarterAug 12Quarterly updateAnnexon, Inc.
Sign inSign in